Analyst picks & changes

Gensia Inc.

(GNSA)

Alex. Brown & Sons analyst Kevin Tang resumed coverage of

Gensia Inc.

(GNSA) with a "buy" and a $29-$35 12-month price target, cautioning that late-stage clinical

Read the full 309 word article

How to gain access

Continue reading with a
two-week free trial.